An example involves mutations in the histone methyltransferase EZH2, whose activity causes reduced expression of RAS association domain-containing protein 5 (RASSF5) and integrin beta chain-2 (ITGB2); these are proteins that are involved in anti-tumor response [293]. This evidence concerns the gene RASSF5 and neoplasm.